Key result
Targeted NGS achieves a ~78% diagnostic yield in consanguineous pediatric DCM, predominantly identifying SCN5A variants.
Why the study?
Pediatric dilated cardiomyopathy is genetically heterogeneous, with limited population-specific genetic data available in Middle Eastern cohorts.
Observational (n=23)
No
Targeted next-generation sequencing in a highly consanguineous Kurdish-Arab pediatric cohort with dilated cardiomyopathy demonstrated a high diagnostic yield of 78.3%, driven largely by a recurrent SCN5A frameshift variant.
Answers are grounded in this paper and cite their sources.
Supports targeted NGS consideration in consanguineous pediatric DCM; leaves open broader validation and generalizability.
Background: Pediatric dilated cardiomyopathy (DCM) is a genetically heterogeneous disorder with limited population-specific genetic data in Middle Eastern cohorts. Methods: Twenty-three pediatric DCM patients from a predominantly Kurdish–Arab consanguineous population underwent comprehensive clinical evaluation and targeted next-generation sequencing (NGS) using a 152-gene cardiomyopathy panel. Variants were classified according to ACMG/AMP guidelines. Results: Targeted NGS identified 163 rare variants; 24 (14.7%) were pathogenic/likely pathogenic (P/LP), 76 (46.6%) were variants of uncertain significance (VUS), and 63 (38.7%) were benign/likely benign. The overall diagnostic yield was 78.3% (18/23). The SCN5A c.1921delC (p.Gln641ArgfsTer3) frameshift variant was the most frequently detected P/LP variant, present in 69.6% of patients. No significant genotype–phenotype correlations were observed for SCN5A c.1921delC regarding age of onset, left ventricular ejection fraction, or valvular/structural abnormalities. Parental consanguinity was high (66.7%), and disease onset occurred early (mean 2.0 ± 3.27 years). Conclusions: This is the first genetic evaluation of a pediatric cohort with DCM from a mixed Kurdish–Arab population. A high diagnostic yield of DCM was found, particularly in consanguineous families, including an SCN5A recurrent variant. The study highlights the utility of targeted NGS in a consanguineous population. Further related studies are required in this region.
No takes yet. Share an insight, caveat, or question.
Fatah et al. (2026) conducted an observational in Pediatric dilated cardiomyopathy (n=23). Targeted next-generation sequencing (152-gene panel) was evaluated on Diagnostic yield (proband with ≥1 pathogenic/likely pathogenic variant). Targeted next-generation sequencing achieved a 78.3% diagnostic yield in a consanguineous Kurdish-Arab pediatric cohort with dilated cardiomyopathy, with an SCN5A frameshift variant present in 69.6% of patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: